Amaç: Bruselloz dünyada en sık görülen bakteriyel zoonotik enfeksiyon hastalığıdır. Çalışmamızda hastalığın endemik olarak görüldüğü Güneydoğu Anadolu bölgesinde ikinci basamak bir hastaneye başvuran ve bruselloz tanısı ile takip edilen 111 bruselloz olgusunun değerlendirilmesi amaçlandı. Yöntem: Çalışmada ikinci basamak bir hastanenin Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji polikliniğine Aralık 2018 – Aralık 2019 tarihleri arasında başvuran bruselloz tanısı ile ayaktan veya yatarak takip edilen 111 olgunun demografik özellikleri, klinik bulguları, olası bulaş yolları, tedavi rejimleri, komplikasyon verileri ve relaps oranları retrospektif olarak incelendi. Bulgular: Hastaların 77’si (%69.3) kadın ve olguların yaş ortalaması 36.4 (yaş aralığı 14-94) idi. Meslek dağılımı açısından, hastaların 69’u (%62.1) ev hanımıydı, 17’si (%15.3) hayvancılıkla uğraşmaktaydı. Olguların 88’inde (%79.2) taze peynir yeme öyküsü vardı. Hastalarda en sık görülen semptomlar, halsizlik (%92.7) ve artralji (%87.3) olarak saptandı. Çalışmaya alınan hastalarda CRP yüksekliği %39.6, anemi %37.8 oranı ile en sık görülen laboratuvar bulguları olarak tespit edildi. Etkilenen organ ve sistemler incelendiğinde olguların 49’unda (%44) hematolojik tutulum, 23’ünde (%20.7) karaciğer tutulumu, 11’inde (%10) osteoartiküler tutulum görüldü. Bir (%0.9) hastada brusellozun nadir bir komplikasyonu olarak izole perikardit, bir (%0.9) hastada da brusella epididimoorşiti saptandı. Çalışmaya dahil edilen hastaların 12’sinde (%10.3) tedavileri bittikten sonraki bir yıllık izlemde relaps saptandı. Sonuç: Bruselloz birçok organ ve dokuyu etkileyebilmektedir. Bu nedenle çok değişik klinik belirti ve bulgularla ortaya çıkabilmekte ve birçok hastalıkla karışabilmektedir. Endemik bölgelerde yaşayan nonspesifik semptom ve bulgular ile başvuran hastalar mutlaka bruselloz açısından değerlendirilmelidir.
Background: Infective endocarditis (IE) is an infection of the heart’s endocardial surface. In recent years, nuclear imaging methods have gained importance in the diagnosis of IE. The present study aims to investigate the imaging potential of 99mTc-labeled vancomycin (99mTc-Vancomycin) as a new agent that would enable the diagnosis of IE in its early stages when it is difficult to diagnose or has small vegetation in the experimental rat model. Methods: 99mTc-Vancomycin scintigraphy was evaluated for its accumulation in IE with Staphylococcus aureus performed in an experimental rat model. Serial planar scintigraphic and biodistribution analysis of infected vegetations are compared to rats with sterile vegetations. The heart was identified as an infected organ, the liver was identified as a non-infected organ and the heart/liver uptake ratio (T / NT ratio) was compared between infective endocarditis and sterile endocarditis groups. Results: Planar scintigrams (in vivo measurements) showed more uptake in the heart of rats in the infective endocarditis group compared to the uptake in the heart of rats in the sterile endocarditis group, but this difference was not statistically significant (p>0.05). From the ex vivo measurements, the 99mTc-Vancomycin heart uptake increased significantly (p = 0.016), liver uptake was significantly decreased (p = 0.045) and the T/NT ratio was significantly higher (p = 0.014) in the infective endocarditis group compared to the sterile endocarditis group. Conclusions: In this experimental study, 99mTc-Vancomycin scintigraphy ensured the detection of ex vivo infected tissue in a rat model of IE. In addition, the absence of significant 99mTc-Vancomycin uptake in the sterile endocarditis group indicates that this agent targeted the infected tissue instead of the sterile inflammatory tissue. Finally, this agent should also be evaluated with animal- specific imaging devices.
15 December 2025 in Infectious Diseases and Clinical Microbiology
Objective: Multidrug-resistant Gram-negative bacteria cause difficult-to-treat infections associated with high mortality. Carbapenems are widely used; however, their overuse has led to the emergence of carbapenem-resistant bacteria. This study aimed to evaluate the indications, clinical and microbiological efficacy, and side effects of ceftazidime-avibactam (CAZ-AVI) and to identify factors influencing mortality, based on data from a large multicenter patient cohort in Türkiye. Materials and Methods: Patients with carbapenem-resistant but CAZ-AVI-susceptible Gram-negative bacterial infections who received CAZ-AVI treatment were retrospectively reviewed. Results: A total of 1245 patients were included. The most common indication for CAZ-AVI use was hospital-acquired pneumonia (47.8%). Klebsiella pneumoniae was the predominant pathogen (81.3%). CAZ-AVI was used as a monotherapy in 80% of cases. Clinical side effects were observed in 8 (0.64%) patients, while laboratory abnormalities occurred in 73 (5.86%). The 7-day, 14-day, and 28-day all-cause mortality rates were 13.8%, 28.9%, and 45.2%, respectively. Microbiological eradication was achieved in 82.3% of patients. Higher Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores at admission, requirement for continuous renal replacement therapy, mechanical ventilation, and elevated C-reactive protein levels were identified as independent risk factors for mortality. Conclusion: This large multicenter real-world analysis demonstrates that CAZ-AVI is an effective treatment option for severe infections with high mortality, such as those caused by carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa.
1 January 2021 in Journal of Dr Behcet Uz Children s Hospital
Objective: Allergic rhinitis (AR) is an inflammatory disease of the nasal mucosa mediated by IgE after exposure to an allergen. The most well known related comorbidity of AR is asthma. This study was planned due to the need for an animal model for studies on AR-asthma coexistence. In this study, the frequency of AR accompanying in the asthma model created in mice,and the usability of the related model in AR studies will be investigated. Methods: In our study, 6-8 week-old, 18-20 g BALB/c mice were used. Chicken egg ovalbumin (OVA Grade V, Sigma) was administered through intraperitoneal (IP) route at doses of 10 μg on days 0 and 14. Mice were exposed to aerosolized 2.5% ovalbumin solution in sterile saline for 30 minutes 3 days a week for 8 weeks, starting 7 days after the last IP administration (21st day). After exposure to OVA, mice were observed for typical signs of AR including sneezing, runny nose, and nasal itching. The final diagnosis of AR was made by histopathological examination of the rhinotracheal tissues of mice. Results: In our study, all mice exposed to ovalbumin received histopathologic diagnosis of AR. Increased number of capillaries lymphocytes, polymorphonuclear leukocytes and eosinophilsper square millimetre of rhinotracheal tissues were calculated in the murine model of AR compared to the the control group. Conclusion: This study introduced a new AR model, not cited in the literature, and induced with the longest-term ovalbumin exposure in the literature. It was concluded that this model, known as the asthma model, can also be used to induce an AR model and can be used in studies investigating coexistence of allergic rhinitis and asthma.
1 January 2024 in Advances in Interventional Cardiology
Introduction: Infective endocarditis (IE) is the infection of the cardiac endothelium and heart valves. The incidence of IE has recently increased due to the widespread use of cardiac device therapies and prosthetic heart valves. Despite modern medical and surgical treatment methods, morbidity...